FDA Needs Rule Change For DMAA Crackdown, Suit Says
By Juan Carlos Rodriguez (November 7, 2013, 2:38 PM EST) -- A weight loss and energy supplement maker hit the U.S. Food and Drug Administration with a lawsuit on Tuesday that accuses it of improperly issuing a detention order on products that contain a controversial stimulant, saying the agency must first go through a formal rule-making process.
Georgia-based Hi-Tech Pharmaceuticals Inc. said in its complaint, filed in D.C. federal court, that the FDA has not engaged in the rule-making process necessary to formally ban the stimulant dimethylamylamine, or DMAA, but still issued an administrative detention order against the company's dietary supplement products that are made with it. Hi-Tech said the FDA has...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!